2014
DOI: 10.1371/journal.pone.0099207
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology of Visceral Leishmaniasis in Algeria: An Update

Abstract: Visceral leishmaniasis (VL), a zoonotic disease caused by Leishmania infantum, is endemic in Algeria. This report describes a retrospective epidemiological study conducted on human VL to document the epidemiological profile at national level. All human VL cases notified by the National Institute of Public Health between 1998 and 2008 were investigated. In parallel all VL cases admitted to the university hospitals of Algiers were surveyed to estimate the underreporting ratio. Fifteen hundred and sixty-two human… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
14
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 30 publications
4
14
0
2
Order By: Relevance
“…The high number of CL cases registered in Algeria may be explained by the extension of classical foci and by the emergence of new foci across the country [26,41,42]. The occurrence of different bioclimatic zones (e.g., Mediterranean climate in the north and humid and semiarid zones in the southern Sahara), the desertification in the steppe of the northern Sahara, and population movements from endemic to non-endemic areas (and vice versa) have likely contributed to the increase in the number of CL cases in Algeria in the past decades [6,29,32,33,43,44].…”
Section: Discussionmentioning
confidence: 99%
“…The high number of CL cases registered in Algeria may be explained by the extension of classical foci and by the emergence of new foci across the country [26,41,42]. The occurrence of different bioclimatic zones (e.g., Mediterranean climate in the north and humid and semiarid zones in the southern Sahara), the desertification in the steppe of the northern Sahara, and population movements from endemic to non-endemic areas (and vice versa) have likely contributed to the increase in the number of CL cases in Algeria in the past decades [6,29,32,33,43,44].…”
Section: Discussionmentioning
confidence: 99%
“…In vitro tests performed on intracellular amastigotes confi rmed that all the strains of L. major isolated from these children displayed a low susceptibility towards Sb (V) containing drugs in the form of Glucantime ® [37]. More recently, 9% of unresponsiveness to antimonial treatment was recorded in children with visceral leishmaniosis [38,39].…”
Section: Canine Leishmanioses In Algeriamentioning
confidence: 99%
“…The Leishmaniasis National Control Program (LNCP) in Algeria was established in 2006, with a vector control program based on pyrethroids as insecticides, but without reservoir host control program [5]. The treatment of the population is provided free of charge in the public sector, with the following antileishmanial medicines included in the national List of Essential Medicines: amphotericin B deoxycholate, liposomal amphotericin B and meglumine antimoniate [6,7]. In spite of the high prevalence, current chemotherapy for leishmaniasis is compromised by high cost, toxicity associated with long-term treatments, route of administration, drug resistance, and different strain sensitivity to the available drugs [8].…”
Section: Introductionmentioning
confidence: 99%